VEEV · CIK 0001393052 · operating
Veeva Systems provides cloud-based software solutions designed for the life sciences industry, serving pharmaceutical, biotechnology, medical device, and consumer products companies globally. The company's platform spans three primary cloud suites: Commercial Cloud, which includes customer relationship management, medical content management, promotional materials management, and analytics tools; Development Cloud, encompassing clinical trial platforms, data management systems, safety and pharmacovigilance tools, and regulatory information management; and Quality Cloud, addressing quality and compliance operations. Additionally, Veeva offers Data Cloud products that provide customer reference data, longitudinal patient insights, healthcare provider engagement metrics, and analytics capabilities to support commercial and clinical decision-making.
Beyond software, Veeva generates revenue through professional services, including systems implementation, deployment planning, solution design, data migration, and systems integration support. The company also provides ongoing managed services such as outsourced systems administration and technical consulting. Veeva operates across North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America, serving the regulated life sciences market with a workforce of approximately 7,300 full-time employees. The company is headquartered in Pleasanton, California and trades on the New York Stock Exchange.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $4.32 | $4.41 | +34.2% | |
| 2024 | $3.22 | $3.27 | +7.3% | |
| 2023 | $3.00 | $3.14 | +14.1% | |
| 2021 | $2.63 | $2.79 | +526.2% | |
| 2020 | $0.42 | $0.44 | -6.7% | |
| 2019 | $0.45 | $0.49 | +104.5% | |
| 2018 | $0.22 | $0.24 | +46.7% | |
| 2017 | $0.15 | $0.16 | +25.0% | |
| 2016 | $0.12 | $0.13 | +33.3% | |
| 2015 | $0.09 | $0.10 | -40.0% | |
| 2013 | $0.15 | $0.20 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-01-31 | 2025-03-24 | 0001393052-25-000022 | SEC ↗ |
| 2024-01-31 | 2024-03-25 | 0001393052-24-000013 | SEC ↗ |
| 2023-01-31 | 2023-03-30 | 0001393052-23-000025 | SEC ↗ |
| 2022-01-31 | 2022-03-30 | 0001393052-22-000017 | SEC ↗ |
| 2021-01-31 | 2021-03-30 | 0001393052-21-000015 | SEC ↗ |
| 2020-01-31 | 2020-03-30 | 0001628280-20-004385 | SEC ↗ |